Main Session
Sep
28
SS 05 - Lung 1: NSCLC Locally Advanced and Oligometastatatic
130 - High-Dimensional Immunophenotyping of Patients with Localized Non-Small Cell Lung Cancer (NSCLC) Reveals Distinct Immune Cell Subsets Predictive of Disease-Free Survival (DFS) in AFT-16 and LCMC3 Phas
Presenter(s)
Nicholas Eustace, MD, PhD - City of Hope National Medical Center, Duarte, CA